Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.

The alpha4beta2 subtype is the most abundant nicotinic acetylcholine receptor (nAChR) in the brain and possesses the high-affinity binding site for nicotine. The alpha4 and beta2 nAChR subunits assemble into two alternate stoichiometries, (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2), which differ...

Full description

Bibliographic Details
Main Authors: Moroni, M, Vijayan, R, Carbone, A, Zwart, R, Biggin, P, Bermudez, I
Format: Journal article
Language:English
Published: 2008
_version_ 1797075860114636800
author Moroni, M
Vijayan, R
Carbone, A
Zwart, R
Biggin, P
Bermudez, I
author_facet Moroni, M
Vijayan, R
Carbone, A
Zwart, R
Biggin, P
Bermudez, I
author_sort Moroni, M
collection OXFORD
description The alpha4beta2 subtype is the most abundant nicotinic acetylcholine receptor (nAChR) in the brain and possesses the high-affinity binding site for nicotine. The alpha4 and beta2 nAChR subunits assemble into two alternate stoichiometries, (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2), which differ in their functional properties and sensitivity to chronic exposure to nicotine. Here, we investigated the sensitivity of both receptor stoichiometries to modulation by Zn2+. We show that Zn2+ exerts an inhibitory modulatory effect on (alpha4)(2)(beta2)(3) receptors, whereas it potentiates or inhibits, depending on its concentration, the function of (alpha4)(3)(beta2)(2) receptors. Furthermore, Zn2+ inhibition on (alpha4)(2)(beta2)(3) nAChRs is voltage-dependent, whereas it is not on (alpha4)(3)(beta2)(2) receptors. We used molecular modeling in conjunction with alanine substitution and functional studies to identify two distinct sets of residues that determine these effects and may coordinate Zn(2+). Zn(2+) inhibition is mediated by a site located on the beta2(+)/alpha4(-) subunit interfaces on both receptor stoichiometries. alpha4(H195) and beta2(D218) are key determinants of this site. Zn2+ potentiation on (alpha4)(3)(beta2)(2) nAChRs is exerted by a site that resides on the alpha4(+)/alpha4(-) of this receptor stoichiometry. alpha4(H195) on the (-) side of the ACh-binding alpha4 subunit and alpha4(E224) on the (+) side of the non-ACh-binding alpha4 subunit critically contribute to this site. We also identified residues within the beta2 subunit that confer voltage dependency to Zn2+ inhibition on (alpha4)(2)(beta2)(3), but not on (alpha4)(3)(beta2)(2) nAChRs.
first_indexed 2024-03-06T23:56:11Z
format Journal article
id oxford-uuid:744ce09f-9fac-4bd3-9ba6-3130fbddbd5e
institution University of Oxford
language English
last_indexed 2024-03-06T23:56:11Z
publishDate 2008
record_format dspace
spelling oxford-uuid:744ce09f-9fac-4bd3-9ba6-3130fbddbd5e2022-03-26T20:01:49ZNon-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:744ce09f-9fac-4bd3-9ba6-3130fbddbd5eEnglishSymplectic Elements at Oxford2008Moroni, MVijayan, RCarbone, AZwart, RBiggin, PBermudez, IThe alpha4beta2 subtype is the most abundant nicotinic acetylcholine receptor (nAChR) in the brain and possesses the high-affinity binding site for nicotine. The alpha4 and beta2 nAChR subunits assemble into two alternate stoichiometries, (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2), which differ in their functional properties and sensitivity to chronic exposure to nicotine. Here, we investigated the sensitivity of both receptor stoichiometries to modulation by Zn2+. We show that Zn2+ exerts an inhibitory modulatory effect on (alpha4)(2)(beta2)(3) receptors, whereas it potentiates or inhibits, depending on its concentration, the function of (alpha4)(3)(beta2)(2) receptors. Furthermore, Zn2+ inhibition on (alpha4)(2)(beta2)(3) nAChRs is voltage-dependent, whereas it is not on (alpha4)(3)(beta2)(2) receptors. We used molecular modeling in conjunction with alanine substitution and functional studies to identify two distinct sets of residues that determine these effects and may coordinate Zn(2+). Zn(2+) inhibition is mediated by a site located on the beta2(+)/alpha4(-) subunit interfaces on both receptor stoichiometries. alpha4(H195) and beta2(D218) are key determinants of this site. Zn2+ potentiation on (alpha4)(3)(beta2)(2) nAChRs is exerted by a site that resides on the alpha4(+)/alpha4(-) of this receptor stoichiometry. alpha4(H195) on the (-) side of the ACh-binding alpha4 subunit and alpha4(E224) on the (+) side of the non-ACh-binding alpha4 subunit critically contribute to this site. We also identified residues within the beta2 subunit that confer voltage dependency to Zn2+ inhibition on (alpha4)(2)(beta2)(3), but not on (alpha4)(3)(beta2)(2) nAChRs.
spellingShingle Moroni, M
Vijayan, R
Carbone, A
Zwart, R
Biggin, P
Bermudez, I
Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title_full Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title_fullStr Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title_full_unstemmed Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title_short Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.
title_sort non agonist binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor an alpha4 alpha4 interface is required for zn2 potentiation
work_keys_str_mv AT moronim nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation
AT vijayanr nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation
AT carbonea nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation
AT zwartr nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation
AT bigginp nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation
AT bermudezi nonagonistbindingsubunitinterfacesconferdistinctfunctionalsignaturestothealternatestoichiometriesofthealpha4beta2nicotinicreceptoranalpha4alpha4interfaceisrequiredforzn2potentiation